Clinical trials
Obesity trials in Argentina
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
85 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 3 |
| 2021 | 6 |
| 2022 | 4 |
| 2023 | 9 |
| 2024 | 6 |
| 2025 | 19 |
| 2026 | 20 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 28 |
| Active, not recruiting | 24 |
| Recruiting | 20 |
| Terminated | 6 |
| Not yet recruiting | 3 |
| Withdrawn | 3 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 31 |
| Novo Nordisk A/S | 17 |
| Amgen | 4 |
| AstraZeneca | 3 |
| Pfizer | 3 |
| Sanofi | 3 |
| Hoffmann-La Roche | 2 |
| Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri | 2 |
| Kailera | 2 |
| Novartis Pharmaceuticals | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 85 |
| Overweight | 46 |
| Diabetes Mellitus, Type 2 | 31 |
| Diabetes Mellitus | 9 |
| Nutrition Disorders | 8 |
| Cardiovascular Diseases | 5 |
| Hypertension | 5 |
| Atherosclerosis | 3 |
| Body Weight | 3 |
| Heart Failure | 3 |
Trials
Showing 26 to 50 of 85. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.